Sigilon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SGTX and buy or sell other stocks, ETFs, and their options commission-free!About SGTX
Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders, Lysosomal Storage Diseases, and Endocrine and Other Chronic Diseases.
CEORogério Vivaldi Coelho, MD, MBA
CEORogério Vivaldi Coelho, MD, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees—
Employees—
SGTX Key Statistics
Market cap56.49M
Market cap56.49M
Price-Earnings ratio-1.86
Price-Earnings ratio-1.86
Dividend yield—
Dividend yield—
Average volume22.59K
Average volume22.59K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$28.00
52 Week high$28.00
52 Week low$3.77
52 Week low$3.77
Stock Snapshot
The current Sigilon Therapeutics(SGTX) stock price is $22.47, with a market capitalization of 56.49M. The stock trades at a price-to-earnings (P/E) ratio of -1.86.
On 2025-12-23, Sigilon Therapeutics(SGTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 22.59K.
The stock's 52-week range extends from a low of $3.77 to a high of $28.00.
The stock's 52-week range extends from a low of $3.77 to a high of $28.00.
People also own
Based on the portfolios of people who own SGTX. This list is generated using Robinhood data, and it’s not a recommendation.